Skip to main content
Kindstar Globalgene Technology, Inc. logo

Kindstar Globalgene Technology, Inc. — Investor Relations & Filings

Ticker · 9960 ISIN · KYG5262E1044 HKEX Human health and social work activities
Open in API
Filings indexed 602 across all filing types
Latest filing 2024-01-24 Transaction in Own Shar…
Country HK Hong Kong
Listing HKEX 9960

About Kindstar Globalgene Technology, Inc.

http://www.kindstar.com.cn

Kindstar Globalgene Technology, Inc. is a leading independent provider of advanced specialty clinical testing services, specializing in esoteric testing. The company maintains the largest esoteric testing portfolio in its market, utilizing internationally-advanced laboratory facilities for clinical testing, scientific research, and applied R&D. Its comprehensive testing menu, featuring over 100 items, covers critical diagnostic areas including hematology, genetic diseases, gynecology, infectious diseases, neurology, and oncology. These services provide physicians and patients access to specialized diagnostics crucial for the diagnosis and treatment of major diseases.

Recent filings

Filing Released Lang Actions
Next Day Disclosure Returns
Transaction in Own Shares Classification · 100% confidence The document is titled 'Next Day Disclosure Return' and relates to changes in issued share capital and share buybacks by Kindstar Globalgene Technology, Inc. It details multiple repurchases of shares over various dates, including quantities and prices, and confirms compliance with listing rules. The document is a regulatory disclosure about share repurchases and changes in issued shares, not a financial report or earnings release. It fits the description of a 'Transaction in Own Shares' filing, which reports the company's buyback activities. The document length is substantial and contains detailed transactional data, confirming it is the report itself, not just an announcement. Therefore, the appropriate classification is POS (Transaction in Own Shares).
2024-01-24 English
Next Day Disclosure Returns
Transaction in Own Shares Classification · 100% confidence The document is titled 'Next Day Disclosure Return' and pertains to changes in issued share capital and share buybacks by Kindstar Globalgene Technology, Inc. It details multiple repurchases of shares, dates, quantities, prices, and confirmations of compliance with listing rules on the Stock Exchange of Hong Kong. The content is a regulatory disclosure about share repurchases and capital changes rather than a financial report or earnings announcement. It is not a full financial report but a regulatory filing about share transactions and capital changes. Therefore, the document fits best under the category 'Transaction in Own Shares' (POS). The document length and detail confirm it is not a brief announcement but a substantive disclosure of share repurchase activity.
2024-01-23 English
Next Day Disclosure Returns
Transaction in Own Shares Classification · 100% confidence The document is titled 'Next Day Disclosure Return' and relates to changes in issued share capital and share buybacks by Kindstar Globalgene Technology, Inc. It details repurchases of shares over multiple dates, confirming compliance with listing rules of the Stock Exchange of Hong Kong (SEHK). The content is a regulatory disclosure about share repurchases and changes in issued shares, not a financial report or earnings release. It is a formal regulatory filing required by the exchange to disclose capital changes and share buybacks. The document is not a report itself but a regulatory disclosure form. Therefore, the most appropriate classification is 'Transaction in Own Shares' (POS), which covers reports of the company buying back or selling its own shares.
2024-01-22 English
Next Day Disclosure Returns
Transaction in Own Shares Classification · 100% confidence The document is titled 'Next Day Disclosure Return' and relates to changes in issued share capital and share buybacks by Kindstar Globalgene Technology, Inc. It details multiple repurchases of shares over various dates, confirming compliance with listing rules of the Stock Exchange of Hong Kong. The content is focused on reporting share repurchase transactions and confirmations related to these transactions, without containing financial statements or earnings data. This matches the description of a 'Transaction in Own Shares' filing, which reports company buybacks or sales of its own shares. The document length is sufficient and contains detailed transactional data, not just an announcement or certification. Therefore, the appropriate classification is 'POS' (Transaction in Own Shares).
2024-01-19 English
Next Day Disclosure Returns
Transaction in Own Shares Classification · 95% confidence The document is titled 'Next Day Disclosure Return' and relates to changes in issued share capital and share buybacks by Kindstar Globalgene Technology, Inc. It details repurchases of shares on various dates, including quantities and prices, and confirms compliance with listing rules. The content is focused on reporting share repurchase transactions and changes in issued shares, consistent with disclosures required by stock exchange rules. There is no indication of a full financial report, earnings release, or management discussion. The document is a regulatory disclosure about share repurchases and capital changes, fitting the category of Transaction in Own Shares (POS). The document length (12,470 characters) supports it being a substantive disclosure rather than a brief announcement. Therefore, the appropriate classification is POS with high confidence.
2024-01-18 English
Next Day Disclosure Returns
Transaction in Own Shares Classification · 100% confidence The document is titled 'Next Day Disclosure Return' and relates to changes in issued share capital and share buybacks by Kindstar Globalgene Technology, Inc. It details multiple repurchases of shares over various dates, confirming compliance with listing rules and providing specifics on the number of shares repurchased, prices, and confirmations by an executive director. The content focuses on share repurchase activities and disclosures required by the Stock Exchange of Hong Kong. This matches the description of a 'Transaction in Own Shares' filing, which reports the company's buyback of its own shares. The document is detailed and substantive, not merely an announcement or certification, so it is not a Regulatory Filing or Report Publication Announcement. Therefore, the correct classification is POS (Transaction in Own Shares).
2024-01-17 English

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.